MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 10 | 0.0 |
Binding Sites | 6 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
Humans | 36 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Phosphorylation | 16 | 0.0 |
Protein Conformation | 3 | 0.0 |
Protein-Serine-Threonine Kinases/*physiology | 3 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 20 | 0.0 |
Signal Transduction | 10 | 0.0 |
Animals | 18 | 0.0 |
Comparative Study | 5 | 0.0 |
Models, Biological | 2 | 0.0 |
Carrier Proteins/metabolism | 2 | 0.0 |
Mutation | 5 | 0.0 |
Protein Isoforms | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 5 | 0.0 |
Rats | 4 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Immunoblotting | 3 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
Enzyme Activation | 16 | 0.0 |
Protein-Serine-Threonine Kinases/chemistry/genetics/*metabolism | 2 | 4.0 |
Cell Line | 10 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Transfection | 5 | 0.0 |
Alleles | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 12 | 1.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
src Homology Domains | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Reactive Oxygen Species/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
*Ultraviolet Rays | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Hela Cells | 3 | 0.0 |
Mutagenesis, Site-Directed | 5 | 0.0 |
Peptide Mapping | 2 | 0.0 |
Apoptosis | 2 | 0.0 |
Caspases/*metabolism | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
Glutathione Transferase/metabolism | 4 | 0.0 |
Kinetics | 4 | 0.0 |
Mice | 8 | 0.0 |
Protein Binding | 5 | 0.0 |
Protein Structure, Tertiary | 6 | 0.0 |
Rabbits | 2 | 0.0 |
Time Factors | 3 | 0.0 |
cdc42 GTP-Binding Protein/metabolism | 3 | 2.0 |
Protein Kinases/*metabolism | 2 | 0.0 |
*Apoptosis | 6 | 0.0 |
Caspases/antagonists & inhibitors/*metabolism | 2 | 3.0 |
Cysteine Proteinase Inhibitors/pharmacology | 5 | 2.0 |
DNA Fragmentation | 3 | 0.0 |
Oligopeptides/pharmacology | 2 | 1.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Receptors, Antigen, T-Cell/physiology | 2 | 1.0 |
3T3 Cells | 3 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
*Caspases | 4 | 7.0 |
Hydrolysis | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Amino Acid Chloromethyl Ketones/pharmacology | 2 | 1.0 |
Cysteine Endopeptidases/*metabolism | 3 | 1.0 |
Poly(ADP-ribose) Polymerases/metabolism | 2 | 1.0 |
Cell Cycle Proteins/*metabolism | 2 | 0.0 |
GTP-Binding Proteins/*metabolism | 2 | 0.0 |
Guanosine Triphosphate/metabolism | 2 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Antigens, CD95/*physiology | 2 | 2.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Jurkat Cells | 2 | 0.0 |
Enzyme Activation/drug effects | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Substrate Specificity | 3 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
Catalysis | 4 | 0.0 |
cdc42 GTP-Binding Protein/physiology | 2 | 11.0 |
Plasmids/metabolism | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
